Innovations in MRD Detection: Leveraging NGS to Gain Insights into Multiple Myeloma and B-ALL
47:55
Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing
1:37:34
The Cancer Expert: "This Common Food Is Making Cancer Worse!"
59:21
Clinical Utility of NGS in Lymphoid Malignancies
51:55
Stratification and Prognosis of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS)
59:12
NGS Assessment of SHM in CLL/SLL: A Practical Comparison of Platforms and Primers
1:02:52
May19 2022 Webinar Video
34:57
Invivoscribe’s Symposium at Next Generation Dx Summit 2021
56:19